Whole Blood Clotting Time Monitoring Frequency After Viper Bite
Check the 20-minute whole blood clotting test (WBCT20) every 6 hours after initial presentation and continue monitoring for at least 48 hours, even after coagulation normalizes, because recurrence of coagulopathy occurs in approximately one-third of patients.
Initial Testing Protocol
Perform WBCT20 immediately upon hospital arrival to establish baseline coagulation status and guide initial antivenom administration decisions 1, 2.
Use a standardized technique: collect 1 mL of whole blood in a clean 5 mL borosilicate glass tube with 10 mm internal diameter, then observe at both 20 and 30 minutes for optimal sensitivity 3, 4.
Reading at both 20 and 30 minutes (WBCT20 and WBCT30) significantly improves diagnostic accuracy, particularly when detecting resolution or recurrence of coagulopathy 3.
Serial Monitoring Schedule
Repeat WBCT every 6 hours after antivenom administration until coagulation normalizes and remains stable 1.
Continue monitoring even after initial normalization because venom-induced consumption coagulopathy (VICC) recurs in 35.7% of patients, requiring additional antivenom doses 1.
Extend observation to at least 48 hours post-antivenom to detect delayed or biphasic coagulopathy 5.
Critical Decision Points Based on Serial Testing
If WBCT remains abnormal at 6 hours post-antivenom, administer an additional 50-100 mL dose depending on severity:
- Incoagulable blood: give 100 mL
- Mild dysfunction: give 50 mL 1
Patients with initially incoagulable blood require higher total antivenom doses (mean 179.2 mL, often 150-200 mL total) and more frequent monitoring 1.
Discrepancies between WBCT20 and WBCT30 results most commonly occur during three critical phases: initial normalization after antivenom, detection of secondary coagulopathy resumption, or final restoration of hemostasis 3.
Test Performance Considerations and Pitfalls
WBCT20 sensitivity ranges from 40-87% depending on venom species and testing conditions, meaning a negative test does NOT rule out coagulopathy 6, 4, 7.
In Russell's viper envenoming specifically, admission WBCT20 detected only 40% of coagulopathy cases (56/140 patients), leading to dangerous delays in antivenom administration 6.
Never delay antivenom based solely on a negative WBCT20 if clinical signs of envenomation are present—the test has a false-negative rate of 13-18% even with trained staff 6, 4.
Confirm positive WBCT20 with PT/INR (cutoff ≥1.4) in asymptomatic patients before administering antivenom, as the false-positive rate reaches 24% in some studies 2.
The Modified Lee and White method demonstrates superior sensitivity (85% vs. 55%) compared to standard WBCT20 and may be preferred where feasible 8.
Monitoring Beyond Coagulation
Observe continuously during antivenom infusion and for at least 30 minutes post-infusion to detect hypersensitivity reactions, which occur in up to 75% of patients 9, 5.
Have epinephrine immediately available (0.3-0.5 mg IM for adults, 0.01 mg/kg for children) before starting antivenom, as 89% of reactions occur within the first hour 5.
Monitor for acute kidney injury, which develops in 2.5% of viper-envenomed patients and may require extended observation 10.
Species-Specific Considerations
Pit viper (Crotalinae) envenomation, which accounts for >95% of North American venomous bites, causes cytotoxic effects with coagulopathy requiring serial WBCT monitoring 11.
Coral snake (Elapidae) bites cause primarily neurotoxic effects without coagulopathy, so WBCT monitoring is not indicated—instead monitor for respiratory compromise 11, 12.
Echis ocellatus (carpet viper) envenoming shows WBCT20 sensitivity of 87.2% with high rates of rebound coagulopathy, necessitating prolonged serial testing 7.